Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foa

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|January 1, 1989
Ontogeny, gene rearrangements and immunophenotype of acute leukaemiasR Foa, N Migone, P Francia di Celle, et al.
Leukemia|August 1, 1987
A human leukemic T cell line (PF-382) inhibits the growth of myeloid and erythroid progenitor cellsG Bellone, R Foa, M T Fierro, et al.
Clinical and Experimental Immunology|October 1, 1987
Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytesR Zambello, T Chisesi, C Agostini, et al.
Leukemia|January 1, 1992
Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findingsR Foa, G Meloni, A Guarini, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
British Journal of Haematology|August 1, 1989
The inhibitory effect of serum from hairy-cell leukaemia patients on normal progenitor cells may disappear following prolonged treatment with alpha-interferonF Lauria, G P Bagnara, L Catani, et al.
Journal of Clinical Immunology|October 1, 1982
Binding of sheep erythrocytes in chronic lymphocytic leukemias of B-cell originG Semenzato, G Pizzolo, F Gerosa, et al.
Bone Marrow Transplantation|July 1, 1990
Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findingsR Foa, G Meloni, S Tosti, et al.
British Journal of Haematology|September 1, 1990
ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crisesC Ponzetto, A Guerrasio, C Rosso, et al.
Leukemia|January 1, 1988
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activityM T Fierro, X S Liao, P Lusso, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|January 1, 1989
Ontogeny, gene rearrangements and immunophenotype of acute leukaemiasR Foa, N Migone, P Francia di Celle, et al.
Leukemia|August 1, 1987
A human leukemic T cell line (PF-382) inhibits the growth of myeloid and erythroid progenitor cellsG Bellone, R Foa, M T Fierro, et al.
Clinical and Experimental Immunology|October 1, 1987
Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytesR Zambello, T Chisesi, C Agostini, et al.
Leukemia|January 1, 1992
Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findingsR Foa, G Meloni, A Guarini, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
British Journal of Haematology|August 1, 1989
The inhibitory effect of serum from hairy-cell leukaemia patients on normal progenitor cells may disappear following prolonged treatment with alpha-interferonF Lauria, G P Bagnara, L Catani, et al.
Journal of Clinical Immunology|October 1, 1982
Binding of sheep erythrocytes in chronic lymphocytic leukemias of B-cell originG Semenzato, G Pizzolo, F Gerosa, et al.
Bone Marrow Transplantation|July 1, 1990
Treatment of residual disease in acute leukemia patients with recombinant interleukin 2 (IL2): clinical and biological findingsR Foa, G Meloni, S Tosti, et al.
British Journal of Haematology|September 1, 1990
ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crisesC Ponzetto, A Guerrasio, C Rosso, et al.
Leukemia|January 1, 1988
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activityM T Fierro, X S Liao, P Lusso, et al.
Pageof 18